Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study-Reference-Cited by-同舟云学术

Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study

Published:2018-11-08 Issue:2 Volume:25 Page:205-212
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Scott Martin J.¹²³^ORCID,Xiang Hua¹,Hart Daniel P.⁴,Palmer Benedict¹,Collins Peter W.⁵,Stephensen David⁴⁶^ORCID,Sima Camelia S.⁷,Hay Charles R. M.¹²⁸^ORCID

Affiliation:

1. UK National Haemophilia Database Manchester UK

2. University Department of Clinical Haematology Manchester Royal Infirmary Manchester UK

3. Institute of Cancer Sciences, Faculty of Biology, Medicine and Health The University of Manchester Manchester UK

4. The Royal London Hospital Haemophilia Centre, Barts and The London School of Medicine and Dentistry Queen Mary University London London UK

5. School of Medicine Cardiff University, University Hospital of Wales Cardiff UK

6. Kent Haemophilia & Thrombosis Centre East Kent Hospitals University NHS Trust Canterbury UK

7. Roche/Genentech South San Francisco California

8. School of Vascular Medicine The University of Manchester Manchester UK

Funder

Roche

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13616

Reference31 articles.

1. Definitions in hemophilia: communication from the SSC of the ISTH

2. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia

3. A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A

4. When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH

5. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emicizumab and unmet needs of patients with hemophilia a who are managed with replacement therapies;Expert Review of Hematology;2024-09-12

2. Primary prophylaxis implementation and long‐term joint outcomes in Swedish haemophilia A patients;Haemophilia;2024-04-04

3. Lower-dose emicizumab prophylaxis: can less be more?;Journal of Thrombosis and Haemostasis;2024-04

4. Comparison between natural rubber knee support and sponge knee support on the protection of knee joint: A crossover randomized controlled study among patients with bleeding disorders;Health Science Reports;2024-04

5. Disease Burden, Clinical Outcomes, and Quality of Life in People with Hemophilia A without Inhibitors in Europe: Analyses from CHESS II/CHESS PAEDs;TH Open;2024-04